New drug BGB-45035 tested for eczema and itchy skin condition
NCT ID NCT06342713
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 40 times
Summary
This study tested a new drug called BGB-45035 for the first time in humans. It looked at safety in healthy volunteers and then in people with autoimmune skin diseases like atopic dermatitis (eczema) and prurigo nodularis (a condition causing intensely itchy bumps). The goal was to find safe doses and see how the body processes the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chengdu Second Peoples Hospital
Chengdu, Sichuan, 610021, China
-
Cmax Clinical Research
Adelaide, South Australia, SA 5000, Australia
-
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
-
Innovate Clinical Research
Waitara, New South Wales, NSW 2077, Australia
-
Lakeland Clinical Trials Wellington
Upper Hutt, 5018, New Zealand
-
Optimal Clinical Trials Ltd
Auckland, 1010, New Zealand
-
Pacific Clinical Research Network Auckland
Takapuna, 0622, New Zealand
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100000, China
-
Suzhou Municipal Hospital
Suzhou, Jiangsu, 215002, China
-
The Affiliated Hospital of Qingdao University Branch West Coast
Qingdao, Shandong, 266555, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 630014, China
-
The First Hospital of China Medical University
Shenyang, Liaoning, 110001, China
-
Xiangya Hospital of Central South University
Changsha, Hunan, 410008, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.